Home › Endometrial Cancer › Virginia › Arlington

Endometrial Cancer clinical trials in Arlington, VA

39 studies for Endometrial Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

RecruitingPhase 1

Site 04, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07814248

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecruitingPhase 2

Inova Fairfax Hospital, Falls Church · 4 mi away
Inova Schar Cancer Institute, Fairfax · 11 mi away

All ages · All sexes · Updated Sep 29, 2026 · NCT05564377

Study of AVZO-021 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2

Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 19 and older · All sexes · Updated Sep 28, 2026 · NCT06586957

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

RecruitingPhase 3

Inova Schar Cancer Institute ( Site 6003), Fairfax · 11 mi away
Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 17, 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RecruitingPhase 1/2

NEXT Oncology, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07109726

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT04585750

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

RecruitingPhase 1

NEXT Oncology, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 3, 2026 · NCT07755436

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

RecruitingPhase 3

Research Site, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 3, 2026 · NCT06989112

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07383506

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

RecruitingPhase 1

Inova Schar Cancer Institute, Falls Church · 4 mi away

Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06774963

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

RecruitingPhase 1/2

Research Site, Fairfax · 11 mi away

Ages 18 to 130 · All sexes · Updated Aug 21, 2026 · NCT05797168

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

RecruitingPhase 1

Normunity Investigational Site, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149

A Study of PHST001 in Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology - Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06840886

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07444814

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06330064

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

RecruitingPhase 1/2

USOR Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06270706

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RecruitingPhase 3

Research Site, Falls Church · 4 mi away
Research Site, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07524322

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05208762

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

RecruitingPhase 2

522, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Jul 16, 2026 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecruitingPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07458347

A Study of LY4175408 in Participants With Advanced Cancer

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07046923

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

NEXT, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

RecruitingPhase 1

NEXT Texas LLC - Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07503808

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05103683

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

RecruitingPhase 1

Dren Investigational Site, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT06999187

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

RecruitingPhase 2

Virginia Cancer Specialists, P.C., Fairfax · 11 mi away

Ages 18 and older · Women · Updated Dec 24, 2025 · NCT06463028

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT05856981

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Feb 13, 2025 · NCT05669430

Endometrial Cancer trials in other cities

Other studies in Arlington

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.